Skip to content
Open access

Integrative profiling of multi-modal plasma cfRNA signatures enables detection and prognostic risk stratification in breast cancer.

Sep 2026 · Genomics · pp. 111324 · 0 citations · 57 references
Medicine

TL;DR

Collectively, multi-modal plasma cfRNA profiling may enable non-invasive breast cancer detection and provide candidate markers for prognostic risk stratification and future precision oncology applications.

Abstract

Breast cancer requires non-invasive biomarkers for accurate detection and risk stratification. We comprehensively profiled plasma cell-free RNA (cfRNA) from 41 patients with malignant and 42 with benign breast lesions using SLiPiR-seq. Multiple cfRNA subtypes displayed distinct expression patterns, and machine-learning models were developed with repeated stratified four-fold cross-validation. The integrated cfRNA model achieved a mean AUC of 0.795, while the cf-miRNA model performed best (AUC: 0.814) and was externally validated in an independent cohort (AUC: 0.867). A three-gene tissue expression signature comprising DLST, DOCK4, and EGFL7 further stratified patients by overall survival in TCGA-BRCA. High-risk tumors showed increased PIK3CA mutations, PI3K-AKT pathway activation, and altered immune features. Single-cell analysis revealed distinct localization of the three genes across epithelial cells, tumor-associated macrophages, cancer-associated fibroblasts, and T-cell populations. Collectively, multi-modal plasma cfRNA profiling may enable non-invasive breast cancer detection and provide candidate markers for prognostic risk stratification and future precision oncology applications.

Read PDF

Similar papers

Open access Sep 2026

Integrative multi-omics profiling and machine learning reveal enhancer RNA signatures for early detection and prognostic stratification in breast cancer

These findings establish eRNAs as a complementary noncoding layer to conventional messenger RNA classifiers, with clinical potential for breast cancer risk stratification, therapeutic guidance, and early detection.

Jun-Huan Xia, Jing-Wen Tian, Yu-Ting Cao et al. · 0 citations
Open access Aug 2026

Expression, prognostic association, and immune microenvironment correlates of C4orf50 in breast cancer: a The Cancer Genome Atlas Breast Invasive Carcinoma (TCGA-BRCA) bioinformatics study

Background Chromosome 4 open reading frame 50 (C4orf50) is a poorly characterized gene whose expression pattern and clinical relevance in breast cancer remain unclear. We aimed to evaluate the expression, prognostic association, immune microenvironment correlates, and transcriptional features associated with C4orf50 in...

Si-Hang Lin, Li-Xia Liu, Jia-Yu Guan et al. · 0 citations
Oct 2026

Convergent molecular evidence identifies a robust seven-gene signature in esophageal squamous cell carcinoma.

Esophageal Squamous Cell Carcinoma (ESCC) is an aggressive gastrointestinal malignancy with unfavorable clinical outcomes, and current molecular biomarkers offer limited clinical utility for early detection and precise risk stratification. In this study, we integrated multi-cohort transcriptomic profiling with systems-...

E. Pavithra, K. R. Unni, Febby Payva et al. · 0 citations
Open access Oct 2026

Genome-Wide DNA methylation profiling of tissue-plasma pairs identifies Novel cfDNA biomarkers for the diagnosis of gastric cancer

Screening for gastric cancer (GC) is critical for improving patient survival, yet current clinical methods suffer from invasiveness and limited sensitivity. The aim of this study is to develop a machine learning model for the non-invasive diagnosis of GC using the whole-genome methylation profile of circulating free DN...

Hai-Ling Ou, J. Miao, Fu-Sheng Ling et al. · 0 citations
Open access Jan 2026

Integrated Bulk and Single‐Cell Transcriptomic Analyses Identify a Five‐Gene Signature Associated With Prognosis and the Tumor Microenvironment in Epstein–Barr Virus–Associated Gastric Cancer

A five‐gene signature with strong diagnostic value and biologically meaningful prognostic relevance in EBVaGC is identified, highlighting fibroblast‐ and B‐cell‐associated microenvironmental programs in aggressive disease.

Luyu Jin, Man Jiang, Yu-Long Pan et al. · 0 citations
Sep 2026

Identification of a circulating miR-6838-5p/miR-195-5p signature in invasive ductal breast carcinoma

The miR-6838-5p/miR-195-5p combination represents a promising circulating miRNA signature for invasive ductal breast carcinoma and its consistent discriminatory performance in the discovery cohort and an independent serum cohort supports further evaluation in larger prospective studies.

Mustafa Barış Zeytunlu, Fazilet Esra Incedere Duzdag, Hüseyin Esin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.